These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1090217)

  • 1. The pharmacokinetics of Norpace.
    Karim A
    Angiology; 1975 Jan; 26(1 Pt 2):85-98. PubMed ID: 1090217
    [No Abstract]   [Full Text] [Related]  

  • 2. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.
    Karim A; Ranney RE; Kraychy S
    J Pharm Sci; 1972 Jun; 61(6):888-93. PubMed ID: 5046104
    [No Abstract]   [Full Text] [Related]  

  • 3. Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.
    Ranney RE; Dean RR; Karim A; Radzialowski FM
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):162-88. PubMed ID: 4104224
    [No Abstract]   [Full Text] [Related]  

  • 4. Disopyramide phosphate: tissue uptake and relationship between drug concentrations in the plasma and myocardium of rats.
    Karim A; Kook C; Campion J; Doherty M
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):222-36. PubMed ID: 921413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic and metabolic study of disopyramide in oral and intravenous administration].
    De Graeve J; Kremers P; Gielen JE
    Therapie; 1977; 32(2):195-204. PubMed ID: 898127
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies of Norpace (Part VIII).
    Laidlaw JC
    Angiology; 1975 Jan; 26(1 Pt 2):144-5. PubMed ID: 1090215
    [No Abstract]   [Full Text] [Related]  

  • 7. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 9. The fate of SU-13197, a new antiarrhythmic drug, in rat and man.
    Shand DG; Cavanaugh JH; Oates JA
    Clin Pharmacol Ther; 1971; 12(5):769-78. PubMed ID: 5568258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal experiments on pharmacokinetics and biotransformation following administration of radioactive-labelled propiramfumarate].
    Duhm B; Maul W; Medenwald H; Patzschke K; Wegner LA
    Arzneimittelforschung; 1974 Apr; 24(4):632-43. PubMed ID: 4406933
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
    Witkowska M
    Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemical study on the pharmacokinetics of propiramfumarate].
    Pütter J; Kroneberg G
    Arzneimittelforschung; 1974 Apr; 24(4):643-51. PubMed ID: 4406767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methods of assay of disopyramide in serum and urine (author's transl)].
    Mallein R; Boucherat M; Rondelet J; Pignat M; Ksavrelof H
    Ann Pharm Fr; 1978; 36(11-12):655-62. PubMed ID: 754645
    [No Abstract]   [Full Text] [Related]  

  • 14. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
    Bryson SM; Whiting B; Lawrence JR
    Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.
    Hinderling PH; Garrett ER
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):199-230. PubMed ID: 978389
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.
    Johnston A; Henry JA; Warrington SJ; Hamer NA
    Br J Clin Pharmacol; 1980 Sep; 10(3):245-8. PubMed ID: 7437241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
    Aitio ML; Allonen H; Kanto J; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disopyramide pharmacokinetics and bioavailability.
    Dubetz DK; Brown NN; Hooper WD; Eadie MJ; Tyrer JH
    Br J Clin Pharmacol; 1978 Sep; 6(3):279-81. PubMed ID: 687507
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isotope technics in studies on dilazep pharmacokinetics and metabolism in the rat].
    Schaumlöffel E; Clausnitzer M
    Arzneimittelforschung; 1972 Oct; 22(10):1643-50. PubMed ID: 4677051
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
    Jounela AJ; Pentikäinen PJ; Oksanen K
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.